Cohance Lifesciences Q1 Results
- BSE: 543064
- NSE: COHANCE
- ISIN: INE03QK01018
- Sector: Biotechnology & Drugs
BSE
429.50
6.30 (1.49%)
6.30 (1.49%)Volume3.00 M
Updated: Mon 18 May, 2026 | 15:53:03
NSE
428.054.85 (1.15%)
4.85 (1.15%)Volume3.97 M
Updated: Mon 18 May, 2026 | 15:40:31
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Cohance Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 490.54 | 588.18 | -27.98% | 394.26 | 24.42% |
| Depreciation/ Amortization | 45.14 | 51.23 | -16.67% | 31.28 | 44.31% |
| Operating Income | 58.77 | 30.94 | -63.10% | 93.82 | -37.36% |
| Net Income | 48.88 | 19.55 | -59.41% | 75.37 | -35.15% |
| Other Operating Expenses Total | 155.84 | 177.00 | -9.74% | 112.94 | 37.98% |
| Net Income Before Taxes | 62.76 | 19.91 | -60.99% | 103.03 | -39.09% |
| Total Revenue | 549.31 | 619.12 | -34.64% | 488.08 | 12.55% |
| Selling/ General/ Admin Expenses Total | 133.32 | 128.99 | -3.76% | 95.89 | 39.03% |
| Diluted Normalized EPS | 1.43 | 0.68 | -58.02% | 1.97 | -27.64% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.